EX-2.1
from 8-K
35 pages
Stock Purchase Agreement by and Between Dragon Scientific, LLC, as Buyer, Oncocyte Corporation as Seller, and Razor Genomics Inc., as the Company, Dated as of December 15, 2022
12/34/56
EX-2.1
from 8-K
98 pages
Agreement and Plan of Merger Among Oncocyte Corporation, Cni Monitor Sub, Inc., Chronix Biomedical, Inc., and David Mackenzie, as the Equityholder Representative Dated as of February 2, 2021 Amended February 23, 2021 Amended and Restated as of April 15, 2021
12/34/56
EX-2.1
from 8-K
99 pages
Agreement and Plan of Merger Among Oncocyte Corporation, Cancer DX Sub, Inc., Insight Genetics, Inc. the Shareholders Who Become a Party Hereto, and Paul A. Dahlhauser, as the Equityholder Representative Dated as of January 10, 2020
12/34/56
EX-2.1
from 8-K
115 pages
Subscription and Stock Purchase Agreement by and Among Oncocyte Corporation, as Buyer, Encore Clinical, Inc., as Parent, and Razor Genomics Inc., as the Company, Dated as of September 4, 2019
12/34/56
